Literature DB >> 29063632

Highway driving safety the day after using sleep medication: the direction of lapses and excursions out-of-lane in drowsy drivers.

Joris C Verster1,2,3, Loes Mooren1, Adriana C Bervoets1, Thomas Roth4.   

Abstract

The primary outcome measure of the on-road driving test is the Standard Deviation of Lateral Position. However, other outcome measures, such as lapses and excursions out-of-lane, also need to be considered as they may be related to crash risk. The aim of this study was to determine the direction of lapses and excursions out-of-lane (i.e. towards/into the adjacent traffic lane or towards/into the road shoulder). In total, data from 240 driving tests were re-analysed, and 628 lapses and 401 excursions out-of-lane were identified. The analyses revealed that lapses were made equally frequently over left (49.4%) and over right (43.3%). In contrast, excursions out-of-lane were almost exclusively directed over right into the (safer) road shoulder (97.3%). These findings suggest that drivers are unaware of having lapses, whereas excursions out-of-lane are events where the driver is aware of loss of vehicle control.
© 2017 The Authors. Journal of Sleep Research published by John Wiley & Sons Ltd on behalf of European Sleep Research Society.

Keywords:  direction; driving; excursions out-of-lane; lapses

Mesh:

Substances:

Year:  2017        PMID: 29063632     DOI: 10.1111/jsr.12622

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  2 in total

1.  Prescription medications for sleep disturbances among midlife women during 2 years of follow-up: a SWAN retrospective cohort study.

Authors:  Daniel H Solomon; Kristine Ruppert; Laurel A Habel; Joel S Finkelstein; Pam Lian; Hadine Joffe; Howard M Kravitz
Journal:  BMJ Open       Date:  2021-05-11       Impact factor: 2.692

2.  Validating lane drifts as a predictive measure of drug or sleepiness induced driving impairment.

Authors:  F R J Vinckenbosch; A Vermeeren; J C Verster; J G Ramaekers; E F Vuurman
Journal:  Psychopharmacology (Berl)       Date:  2020-01-03       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.